XML 80 R58.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jan. 01, 2024
Dec. 20, 2023
Aug. 01, 2023
Aug. 27, 2018
Oct. 31, 2024
Aug. 31, 2024
Aug. 31, 2023
Jul. 31, 2022
Apr. 30, 2022
May 31, 2020
Oct. 31, 2019
Jul. 31, 2019
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Apr. 04, 2022
Loss Contingencies [Line Items]                                
Payment in cash                             $ 3,089,645  
Options to acquire shares                 144,191            
Weighted exercise price                 $ 10.71              
Warrants to purchase shares                 4,424              
Exercise price                 $ 7.32              
Expiration date                 Apr. 22, 2031              
Options remaining to be exercised                           31,013    
Purchase agreement description                           As consideration for the Petito Services, the Owner is entitled to receive: (i) a base salary of $12,000 per month during the term of the Petito Services Agreement, (ii) a royalty payment equal to three percent (3%) of the actual collections from net sales of certain products the Owner develops or co-develops that reach commercialization, (iii) a royalty payment equal to five percent (5%) for the first $50.0 million in aggregate collections from net sales of certain future products and a royalty payment of two and one-half percent (2.5%) on aggregate collections from net sales of certain future products on any amounts exceeding $50.0 million but up to $100.0 million, (iv) $500,000 in cash in the event that 510(k) clearance is issued for any future product accepted by the Company and (v) $1.0 million in cash in the event that a U.S. patent is issued for a certain product; provided that with respect to the incentive payments described in (iv) and (v) of the foregoing, the Owner shall not earn more than $2.5 million.    
Accredited Investors [Member]                                
Loss Contingencies [Line Items]                                
Issuance of shares                 165,738              
Cost of Sales [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties                           $ 0 991,099  
Sub License Agreement [Member]                                
Loss Contingencies [Line Items]                                
License agreement and royalties description       In August 2018, the Company entered an exclusive, world-wide sublicense agreement with CGI Cellerate RX to distribute certain hydrolyzed collagen products, including CellerateRX Surgical, into the surgical and wound care markets. Pursuant to the Sublicense Agreement, the Company paid royalties of 3-5% of annual collected net sales of these products.                        
BIAKOS License Agreement [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties                           $ 177,005 $ 130,000  
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Minimum [Member]                                
Loss Contingencies [Line Items]                                
Royalty percentage                       2.00%        
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member]                                
Loss Contingencies [Line Items]                                
Royalty percentage                       4.00%        
BIAKOS License Agreement [Member] | Rochal Industries LLC [Member] | Maximum [Member] | Forecast [Member]                                
Loss Contingencies [Line Items]                                
Annual royalty                         $ 150,000      
BIAKOS Agreement [Member] | Maximum [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties                       $ 1,000,000        
ABF License Agreement [Member]                                
Loss Contingencies [Line Items]                                
Increase in royalty annual percentage                     10.00%          
ABF License Agreement [Member] | Minimum [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties                     $ 50,000          
Royalty percentage                     2.00%          
ABF License Agreement [Member] | Maximum [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties                     $ 75,000          
Royalty percentage                     4.00%          
ABF License Agreement [Member] | Maximum [Member] | Product and Service, Other [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties                     $ 500,000          
Debrider License Agreement [Member]                                
Loss Contingencies [Line Items]                                
Increase in royalty annual percentage                   10.00%            
Payment of cash                   $ 1,000,000            
Debrider License Agreement [Member] | Rochal [Member]                                
Loss Contingencies [Line Items]                                
Cash                   $ 500,000            
Debrider License Agreement [Member] | Minimum [Member]                                
Loss Contingencies [Line Items]                                
Royalty percentage                   2.00%            
Annual royalty                   $ 100,000            
Debrider License Agreement [Member] | Maximum [Member]                                
Loss Contingencies [Line Items]                                
Royalty percentage                   4.00%            
Annual royalty                   $ 150,000            
Payment for additional royalties                   $ 1,000,000            
Precision Healing Merger Agreement [Member]                                
Loss Contingencies [Line Items]                                
Cash consideration                 $ 125,966              
Payment in cash                 $ 600,000              
Share price                 $ 27.13             $ 30.75
Options to acquire shares                 144,191              
Weighted exercise price                 $ 10.71              
Contingent consideration payments receivable                 $ 10,000,000.0              
Precision Healing Merger Agreement [Member] | Warrant [Member]                                
Loss Contingencies [Line Items]                                
Warrants to purchase shares                 4,424              
Exercise price                 $ 7.32              
Expiration date                 Apr. 22, 2031              
Precision Healing Merger Agreement [Member] | Warrant One [Member]                                
Loss Contingencies [Line Items]                                
Warrants to purchase shares                 12,301              
Exercise price                 $ 12.05              
Expiration date                 Aug. 10, 2030              
Precision Healing Merger Agreement [Member] | Accredited Investors [Member]                                
Loss Contingencies [Line Items]                                
Issuance of shares                 165,738              
Scendia Purchase Agreement [Member]                                
Loss Contingencies [Line Items]                                
Cash               $ 1,600,000                
Acquisition consideration transferred               $ 7,600,000                
Issuance of common stock for purchase of assets               291,686                
Number of shares withheld               94,798                
Earnout consideration               $ 10,000,000.0                
Number of shares issuable               486,145                
Earnout payment         $ 1,100,000   $ 693,000                  
Applied Asset Purchase Agreement [Member]                                
Loss Contingencies [Line Items]                                
Cash consideration     $ 16,792,037                          
Contingent consideration payments receivable     $ 893,000                          
Issuance of common stock for purchase of assets     73,809                          
Assets purchase price     $ 15,250,000                          
Assets purchase price           $ 625,000                    
Services Agreement [Member]                                
Loss Contingencies [Line Items]                                
Purchase agreement description     As consideration for the Petito Services, the Owner is entitled to receive: (i) a base salary of $12,000 per month during the term of the Petito Services Agreement, (ii) a royalty payment equal to three percent (3%) of the actual collections from net sales of certain products the Owner develops or codevelops that reach commercialization, (iii) a royalty payment equal to five percent (5%) for the first $50.0 million in aggregate collections from net sales of certain future products and a royalty payment of two and one-half percent (2.5%) on aggregate collections from net sales of certain future products on any amounts exceeding $50.0 million but up to $100.0 million, (iv) $500,000 in cash in the event that 510(k) clearance is issued for any future product accepted by the Company and (v) $1.0 million in cash in the event that a U.S. patent is issued for a certain product; provided that with respect to the incentive payments described in (iv) and (v) of the foregoing, the Owner shall not earn more than $2.5 million.                          
License Agreement [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties $ 50,000                              
Outstanding units percentage   10.00%                            
License Agreement [Member] | Royalty Agreement Terms [Member]                                
Loss Contingencies [Line Items]                                
Payment for additional royalties $ 100,000                              
License Agreement [Member] | Minimum [Member]                                
Loss Contingencies [Line Items]                                
Royalty expense percentage   1.50%                            
License Agreement [Member] | Maximum [Member]                                
Loss Contingencies [Line Items]                                
Royalty expense percentage   3.00%